Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Continuous glucose monitoring (CGM) has provided new measures of glycemic control that link to diabetes complications. This study investigated the association between the time in range (TIR) assessed by CGM and diabetic retinopathy (DR). RESEARCH DESIGN AND METHODS: A total of 3,262 patients with type 2 diabetes were recruited. TIR was defined as the percentage of time spent within the glucose range of 3.9–10.0 mmol/L during a 24-h period. Measures of glycemic variability (GV) were assessed as well. DR was determined by using fundus photography and graded as 1) non-DR; 2) mild nonproliferative DR (NPDR); 3) moderate NPDR; or 4) vision-threatening DR (VTDR). RESULTS: The overall prevalence of DR was 23.9% (mild NPDR 10.9%, moderate NPDR 6.1%, VTDR 6.9%). Patients with more advanced DR had significantly less TIR and higher measures of GV (all P for trend <0.01). The prevalence of DR on the basis of severity decreased with ascending TIR quartiles (all P for trend <0.001), and the severity of DR was inversely correlated with TIR quartiles (r = −0.147; P < 0.001). Multinomial logistic regression revealed significant associations between TIR and all stages of DR (mild NPDR, P = 0.018; moderate NPDR, P = 0.014; VTDR, P = 0.019) after controlling for age, sex, BMI, diabetes duration, blood pressure, lipid profile, and HbA1c. Further adjustment of GV metrics partially attenuated these associations, although the link between TIR and the presence of any DR remained significant. CONCLUSIONS: TIR assessed by CGM is associated with DR in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Time in range is associated with the risk of microvascular complications and can be used for assessment of glycemic management (57).”
In the citing paper
“These results align with existing literature that emphasizes the clinical benefits of higher TIR, including reduced complications and improved overall health outcomes for individuals with diabetes19,22–24.”
From Impact of digital health interventions on glycemic control and weight management. (2025) · cites this paper as [22]
In the citing paper
“Most recently, the beneficial effects of new medications, such as sodium glucose cotransporter-2 (SGLT-2) agents have helped individuals with type 1 diabetes increase TIR (49-51).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [49]
In the citing paper
“TIR has been found to be strongly associated with the development or progression of diabetic retinopathy and microalbuminuria in type 1 and type 2 DM.16 17”
From Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease (2020) · cites this paper as [17]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Wilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 2×
“However, HbA1c is unreliable in patients with anemia, hemoglobinopathies, or iron deficiency, and in patients who are pregnant (7).”
BackgroundSelf-citationContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Cited by
Items 301–400 of 568
Su, H., Ni, J., Lu, J., Lu, W., Zhu, W. M., Wang, Y., Ma, X., Peng, D., & Zhou, J. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02993-1 · Cited by 6
Self-citationLifestyle modification in atrial fibrillation: Mechanisms, phenotypes and ablation outcomes
Grigoriou, K., Karakasis, P., Theofilis, P., Pamporis, K., Vlachakis, P. K., Apostolos, A., Ktenopoulos, N., Fyntanidou, B., Karagiannidis, E., Patoulias, D., et al. (2026) · Experimental Physiology · doi:10.1113/ep093386 · Cited by 6
Liu, J., Wei, Y., Zang, P., Wang, W., Feng, Z., Yuan, Y., Zhou, H., Zhang, Z., Lei, H., Yang, X., et al. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00863-4 · Cited by 6
Ehrhardt, N. M., Aroda, V. R., Galindo, R. J., Peters, A. L., & Shubrook, J. H. (2023) · Clinical Diabetes · doi:10.2337/cd23-0047 · Cited by 6
Sukmawati (2025) · Journal of Digital Health Innovation and Medical Technology · Cited by 6
Understanding Clinical Inertia in Diabetes
Raveendran, A. V. (2019) · Journal of Social Health and Diabetes · doi:10.1055/s-0039-1694300 · Cited by 6
Continuous Glucose Monitoring of Glycemic Variability During Fasting Post-Sleeve Gastrectomy
Al‐Ozairi, E., Samad, A. E., Kandari, J. A., Taghadom, E., Adam, S., le Roux, C. W., & Syed, A. A. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04505-4 · Cited by 6
Lee, Y., Kim, D. M., Yu, J. M., Choi, K. M., Kim, S. G., Park, K. S., Son, H.-S., Chung, C. H., Ahn, K. J., Lee, S. H., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14959 · Cited by 6
Kudo, A., Machii, N., Ono, T., Saito, H., Oshiro, Y., Takahashi, R., Oshiro, K., Taneda, Y., Higa, M., Nakachi, K., et al. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003302 · Cited by 6
Sun, Q., Yang, P. C., Gu, Q., Gu, W.-S., Wang, W., Wang, J., & Mao, X. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108738 · Cited by 6
Si, Y., Shen, Y., Lu, J., Ma, X., Zhang, L., Mo, Y., Lu, W., Zhu, W., Bao, Y., Hu, G., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02201-y · Cited by 6
Self-citationGibb, F. W., Jennings, P. L., Leelarathna, L., & Wilmot, E. G. (2020) · British Journal of Diabetes · doi:10.15277/bjd.2020.240 · Cited by 6
Sawada, S., Kodama, S., Tsuchiya, S., Kurosawa, S., Endo, A., Sugawara, H., Hosaka, S., Kawana, Y., Asai, Y., Yamamoto, J., et al. (2020) · Clinical Obesity · doi:10.1111/cob.12409 · Cited by 6
Chiang, J., Manski-Nankervis, J.-A. E., Thuraisingam, S., Jenkins, A. J., O'Neal, D. N., Mair, F. S., Jani, B., Nicholl, B. I., & Furler, J. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108451 · Cited by 6
Chai, S., Wu, S., Xin, S., Yuan, N., Sun, J., Zhang, X., & Ji, L. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001914 · Cited by 6
Gómez, A. M., Diana Cristina Henao, C., Rebolledo, M., Jaramillo, P., Múñoz, Ó., Laura María Niño, G., & Yepes, C. A. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221108424 · Cited by 6
Isaac, S., Collin, Y., & Patel, C. J. (2025) · arXiv (Cornell University) · doi:10.48550/arxiv.2510.04386 · Cited by 6
Vasilijević, J., Kovačević, I., Polovina, S. P., Dačić-Krnjaja, B., Kalezić, T., Miletic, S., Barri, L. A., Stanca, S., Ferrari, F., & Ješić, M. D. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070696 · Cited by 5
A CGM-Based model for predicting hypoglycemia in type 2 diabetes patients with TIR in target
Lu, J., Chen, D., Lin, B., Liu, Z., Yang, Y., He, L., Yan, J., Yang, D., & Xu, W. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01713-9 · Cited by 5
Self-citationLee, M. J., Seo, B.-J., & Cho, J. (2025) · Life · doi:10.3390/life15101543 · Cited by 5
Involvement of cellular and enzymatic aspects in the complexity of diabetic neuropathy
Gupta, A., Gupta, T., Singh, T. G., & Singh, R. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2581880 · Cited by 5
Song, J., Wang, J., Wan, J., Lu, Y., Wang, W., Li, L., Wang, J. B., Wei, L., & Yin, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1733037 · Cited by 5
Biomarkers in diabetes mellitus: contributions and discrepancies of new technologies. A case report
Mialon, F., Catargi, B., Rami, L., Barat, P., Bedel, A., Lacape, G., Bérard, A. M., & Beauvieux, M.-C. (2021) · Annales de biologie clinique · doi:10.1684/abc.2021.1680 · Cited by 5
Moreno-Fernández, J., Díaz-Soto, G., Girbés, J., & Arroyo, F. J. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231178022 · Cited by 5
The role of mannose-binding lectin (MBL) in diabetic retinopathy: A scoping review
Dias, P. B., Messias-Reason, I., Hokazono, K., & Nisihara, R. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106863 · Cited by 5
Ajjan, R., Battelino, T., Seufert, J., Blin, P., de Pouvourville, G., Vicaut, É., Carcaillon‐Bentata, L., Levrat‐Guillen, F., Cosson, E., & Joubert, M. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-085961 · Cited by 5
Barua, S., Upadhyay, D., Berube, L. T., Popp, C. J., Curran, M., Pompeii, M. L., Hu, L., Alemán, J. O., Bergman, M., & Sevick, M. A. (2025) · Diabetic Medicine · doi:10.1111/dme.70052 · Cited by 5
Shan, X., Yao, S., Hu, B., Xu, C., Cao, Y., & Dai, W. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s526784 · Cited by 5
Glucose monitoring in diabetes: from clinical studies to real‐world practice
Sagar, R. C., Abbas, A., & Ajjan, R. (2019) · Practical Diabetes · doi:10.1002/pdi.2215 · Cited by 5
Flash Continuous Glucose Monitoring: A Practical Guide and Call to Action for Pharmacists
Cowart, K., & Zgibor, J. C. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211000273 · Cited by 5
Time-related OCT-A changes in preclinical retinopathy and their association with systemic factors
Стулова, А. Н., Семенова, Н. С., Zheleznyakova, A. V., Akopyan, V. S., & Липатов, Д. В. (2021) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2021-6.6-1.14 · Cited by 5
Medical Certification of Pilots Through the Insulin-Treated Diabetes Mellitus Protocol at the FAA
Stanwyck, L. K., DeVoll, J. R., Pastore, J., Gamble, Z., Poe, A., & Gui, G. V. (2022) · Aerospace Medicine and Human Performance · doi:10.3357/amhp.6107.2022 · Cited by 5
Bailey, T. S., Bode, B. W., Wang, Q., Knights, A. W., & Chang, A. M. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01400-w · Cited by 5
Leveraging Continuous Glucose Monitors to Reduce the Risk of Diabetic Retinopathy
Everett, E. M. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.0718 · Cited by 5
Technological Innovations in Type 1 Diabetes Mellitus Management: A Narrative Review
Gunatilake, S. S. C. (2024) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v15i1.7534 · Cited by 5
Heald, A. H., Stedman, M., Warner-Levy, J. J., Belston, L., Paisley, A. N., Patel, R., White, A., Jude, E. B., Gibson, M., Habte‐Asres, H. H., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01648-w · Cited by 5
Jiang, W., Li, L., Wang, W., Liang, Y., Bai, X., Xu, Y., Guo, Q., Ge, L., Liang, J., Lü, B., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1573963 · Cited by 5
Kurozumi, A., Okada, Y., & Tanaka, Y. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0577 · Cited by 5
Lu, J., Pan, Y., Tu, Y., Zhang, P., Zhou, J., & Yu, H. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.01.012 · Cited by 5
Self-citationCho, K. Y., Nomoto, H., Nakamura, A., Kawata, S., Sugawara, H., Takeuchi, J., Nagai, S., Omori, K., Tsuchida, K., Miya, A., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13498 · Cited by 5
Liu, Y., Yu, J., Ma, C., He, S., Ping, F., Zhang, H., Li, W., Xu, L., Xiao, X., & Li, Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-6344 · Cited by 5
Chu, C., Zhang, Y., Deng, F., & Zhang, L. (2025) · Journal of Hypertension · doi:10.1038/s41387-025-00404-8 · Cited by 5
Self-citationDhankhar, S., Mahajan, S., Chauhan, S., Saini, M., Garg, N., & Singh, T. G. (2024) · Current Bioactive Compounds · doi:10.2174/0115734072322250240924081053 · Cited by 4
Ye, H., Ma, Z., Zong, Q., Zhu, Q., Yan, Y., Yang, S., Xiang, P., & Zou, H. (2025) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2025.100413 · Cited by 4
Ni, J., Chen, L., Su, H., Cai, J., Wang, C., Lu, W., Wang, Y., Lu, J., Xia, T., & Zhou, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70214 · Cited by 4
Self-citationCai, J., Peng, P., Lu, J., Shen, Y., Wang, C., Mo, Y., Lu, W., Zhu, W., Xia, T., & Zhou, J. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3813 · Cited by 4
Self-citationWang, C., Ji, X., Ji, N., Yan, Q.-F., Xu, H., Wang, X., Chen, X., & Lu, C.-F. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01937-w · Cited by 5
Yin, J., Han, M., Li, L., Li, Y., Liu, Z., Yang, J., & Liu, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s331833 · Cited by 4
Liu, Y., Jiang, H., Ruan, B., Liu, Y., Le, S., Fu, X., & Wang, S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.925870 · Cited by 4
Trends in Time in Range–Related Publications and Clinical Trials: A Bibliometric Review
Patel, P. M., Abaniel, R. M., Dogra, N., Lo, C. B., Frazzitta, M. A., & Virdi, N. S. (2023) · Diabetes Spectrum · doi:10.2337/ds22-0085 · Cited by 4
Pratama, K. G., Angelia, M., Amelia, Y. S., & Sukmadi, N. (2024) · Clinical Diabetology · doi:10.5603/cd.99931 · Cited by 4
Oi-Yo, Y., Urai, S., Yamamoto, A., Takayoshi, T., Yamamoto, M., Hirota, Y., & Ogawa, W. (2024) · Endocrine · doi:10.1007/s12020-024-03971-5 · Cited by 4
Association of time in range with cognitive impairment in middle-aged type 2 diabetic patients
Liu, Y., Liu, Y., Qiu, H.-N., Haghbin, N., Li, J., Li, Y., Jiang, W., Xia, L., Wu, F., Lin, C.-Y., et al. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01772-5 · Cited by 4
Varughese, M. S., Nayak, A., & Varadhan, L. (2025) · Eye · doi:10.1038/s41433-025-03730-4 · Cited by 4
Newson, R. S., Artime, E., Bower, J. K., Spaepen, E., Liao, B., Bhattacharya, I., & Battelino, T. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s511332 · Cited by 4
Glycemic control after switching to faster aspart in adults with type 1 diabetes
Fadini, G. P., Boscari, F., Falaguasta, D., Ferretto, S., Maran, A., Avogaro, A., & Bruttomesso, D. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01745-2 · Cited by 4
The Implication of Time-in-Range for the Management of Diabetes in India: A Narrative Review
Tripathi, S., Jindal, S., Chawla, M. S., Gupta, A., Jha, S. K., Phadke, U., & Lathia, T. B. (2022) · Clinical Diabetology · doi:10.5603/dk.a2022.0018 · Cited by 4
Hashimoto, S., Yasuda, M., Fujiwara, K., Ueda, E., Nakamura, S., Hirakawa, Y., Higashioka, M., Hata, J., Ninomiya, T., & Sonoda, K. (2022) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-022-05839-8 · Cited by 4
Harris, S. B., Mohammedi, K., Bertolini, M., Carlyle, M. H., Walker, V., Zhou, F. L., Anderson, J. E., & Seufert, J. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15240 · Cited by 4
Litwak, L., Carreño, N., Carnero, R., Daín, A., Grosembacher, L., Musso, C., PROIETTI, A. E., Rista, L., Rovira, G., Rubín, G., et al. (2020) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v54i3.455 · Cited by 4
Hybrid Closed-Loop Insulin Delivery Systems for People With Type 1 Diabetes
Service, C. H. T. A. (2021) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2021.50 · Cited by 4
Glutamic acid decarboxylase immunotherapy for type 1 diabetes
Ludvigsson, J. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000748 · Cited by 4
Deng, Z., Wang, S., Lu, J., Zhang, R., Zhang, L. J., Lu, W., Zhu, W., Bao, Y., Zhou, J., & Hu, C. (2023) · Endocrine · doi:10.1007/s12020-023-03484-7 · Cited by 4
Self-citationKim, K. J., Park, Y. S., Sun, E., Jo, E., Shinn, J., Yim, H. W., Kim, C. O., & Kim, H. (2025) · Yonsei Medical Journal · doi:10.3349/ymj.2024.0261 · Cited by 3
Okuno, T., Macwan, S. A., Norman, G. J., Miller, D. R., Reaven, P. D., & Zhou, J. Y. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261416922 · Cited by 3
Self-citationCichosz, S. L., Hangaard, S., Kronborg, T., Vestergaard, P., & Jensen, M. H. (2026) · Diabetes Technology and Obesity Medicine · doi:10.1177/29986702261432757 · Cited by 3
Yao, Y., Hu, Z., Mo, Y., Han, M., Cao, L., Cai, J., Ma, X., Lu, J., Wu, X., & Zhou, J. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70702 · Cited by 3
Self-citationAmpudia‐Blasco, F. J., Ugarte, E., Chico, A. I., García-Alemán, J., & Galan-Barroso, M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221087270 · Cited by 3
Aleppo, G., Bode, B. W., & Carlson, A. L. (2022) · Clinical Diabetes · doi:10.2337/cd21-0056 · Cited by 3
Dynamic circadian fluctuations of glycemia in patients with type 2 diabetes mellitus
Vásquez-Muñoz, M., Arce‐Álvarez, A., Álvarez, C., Ramírez‐Campillo, R., Crespo, F., Arias, D., Salazar‐Ardiles, C., Izquierdo, M., & Andrade, D. C. (2022) · Biological Research · doi:10.1186/s40659-022-00406-1 · Cited by 3
Alazmi, A. A., Brema, I. A., ALZAHRANI, S. H., & Almehthel, M. S. (2024) · Cureus · doi:10.7759/cureus.63947 · Cited by 3
Olivieri, C., Salato, M., Campanella, A., Marolo, P., Parisi, G., Neri, G., Toro, M. D., Scarmozzino, A., Broglio, F., Borrelli, E., et al. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02354-6 · Cited by 3
Cai, X., Hu, S., Lin, C., Wu, J. T., Wang, J., Wang, Z., Zhang, X., Wang, X., Xu, F., Chen, L., et al. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003477 · Cited by 3
Cai, Q., Zhao, P., Chen, X., Yu, S., Guo, L., & Pan, Q. (2025) · Aging Medicine · doi:10.1002/agm2.70044 · Cited by 3
Yang, L., Han, M.-M., He, Q., Liu, Z., Liang, D., Hou, J.-T., Zhang, Y., & Liu, Y. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i12.654 · Cited by 3
Yao, S., Xing, S., Shan, X., Dai, W., Cao, Y., & Hu, B. (2025) · Endocrine · doi:10.1007/s12020-025-04206-x · Cited by 3
Xie, L., Zhang, R., Hu, C., Li, T., Zhang, Z.-P., Jin, M., Gao, R., Zhang, Z.-R., Wei, Z., Ju, Y., et al. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110329 · Cited by 3
Yuan, Y., Lü, B., Guo, Q., Wang, W., Feng, Z., Jin, X., Zhou, H., Liu, J., Lei, H., Yang, X., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109179 · Cited by 3
su, Z., Li, H., Zheng, Y., Xie, P., Ng, T. K., Qiu, K., & Zhang, G. (2023) · Research Square · doi:10.21203/rs.3.rs-3584831/v1 · Cited by 3
CADTH (2024) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2024.993 · Cited by 2
Lee, H., Yang, M., Kim, H. Y., & Kim, J. (2025) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2550214.107 · Cited by 2
Georeli, E., Sotiriou, G., Chainoglou, A., Galli‐Τsinopoulou, A., Stabouli, S., & Christoforidis, A. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113132 · Cited by 2
Yang, Y., Liu, Z., HUANG, Y. ‐., Deng, H., Yang, X., Yan, J., Zeng, L., Lin, B., & Xu, W. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02204-2 · Cited by 2
Su, H., Ni, J., Lu, J., Lu, W. J., Zhu, W., Wang, Y., Ma, X., Peng, D., & Zhou, J. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70152 · Cited by 2
Self-citationGoyal, M. K., Hatwal, J., Desai, R., Sehgal, T., & Batta, A. (2026) · World Journal of Diabetes · doi:10.4239/wjd.115820 · Cited by 2
Gerdes, C., Werner, C., Kloos, C., Lehmann, T., Wolf, G., Müller, U., & Muller, N. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1192-3761 · Cited by 2
AGP und Ernährung – Mit CGM postprandiale Glukoseverläufe analysieren
Kroeger, J., Siegmund, T., Schubert, O., Keuthage, W., Lettmann, M., Richert, K., & Pfeiffer, A. F. H. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1310-2736 · Cited by 2
Nah, E., Cho, S., Park, H., Noh, D., Kwon, E., & Cho, H. (2022) · Healthcare · doi:10.3390/healthcare10050824 · Cited by 2
Показники контролю рівня глікемії: сучасний стан питання
Kondratyshyn, A. R., Fik, M. S., Наумова, У. О., & Naumova, L. V. (2022) · Endokrynologia · doi:10.31793/1680-1466.2022.27-2.147 · Cited by 2
Recent updates in factors associated with incidence and screening of diabetic eye disease
Sone, H. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13991 · Cited by 2
Expert viewpoint on the position of Vildagliptin in a cardiology clinic in Indian clinical settings
Das, D. R., Shah, C. P., & Warrier, S. B. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.17.2.1252 · Cited by 2
Glucose Control and Diabetic Retinopathy: Is there More Than Meets the Eye?
Bhat, S., & Menon, A. S. (2023) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_cdrp_22_22 · Cited by 2
Yuan-yuan, C., Shuli, Q., Yanjun, L., Yuqi, Z., Xu, W., & Li, C. (2020) · Global Journal of Obesity Diabetes and Metabolic Syndrome · doi:10.17352/2455-8583.000042 · Cited by 2
Schultz, A. N. Ø., Christensen, R., Bollig, G., Kidholm, K., & Brandt, F. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058728 · Cited by 2
Interpretación del monitoreo continuo de glucosa: una visión práctica
Coronel-Restrepo, N., Rincón, A. R., Palacio, A., Delgado, M. R., & Botero, J. F. (2023) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.10.1.764 · Cited by 2
Simonson, D. C., Testa, M. A., Ekholm, E., Su, M., Vilsbøll, T., Jabbour, S. A., & Lind, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae105 · Cited by 2
Liu, Y., Peng, X., Qiu, C., & Shao, J. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01313-z · Cited by 2
Clinical assessment of retinopathy in type 2 diabetes: a cross-sectional study
Amelia, R., Sari, M. D., Virgayanti, V., Wijaya, H., Situmorang, R. M., & Nadyah, S. (2024) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr.2024.144910 · Cited by 2
Ma, W., Li, J., Shao, X., Yin, X., Xie, C., Wang, F., & Li, Y. (2025) · Open Medicine · doi:10.1515/med-2025-1158 · Cited by 2
Metadata
- Authors
- Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., & Jia, W.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Zhou, Jian
- Jia, Weiping
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-09-10
- Volume
- 41
- Issue
- 11
- Pages
- 2370-2376
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2891930016
- Cited by
- 517
- References
- 32
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 61 · 2023: 70 · 2022: 87 · 2021: 85 · 2020: 71 · 2019: 40 · 2018: 1
- FWCI
- 39.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81100590)
- Shanghai Municipal Education Commission (20161430)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- time in range, continuous glucose monitoring, diabetic retinopathy, type 2 diabetes, glycemic variability, glycemic control, non-proliferative diabetic retinopathy, vision-threatening diabetic retinopathy, retinopathy severity
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Fundus Oculi, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Reference Values, Retrospective Studies, Time Factors, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.